Furthermore, our results showed a slight but significant increase in plasma CCL2 levels in patients receiving drug treatment for a long-term period; this finding suggests that although the treatment increases the plasma levels, the magnitude of the increase is associated with response to the treatment, possibly reflecting treatment-induced CCL2 production in the tumor. This evidence concerns the gene CCL2 and neoplasm.